A lawsuit accuses WPATH of making deceptive claims about transgender medical “treatments” for minors, minimizing the ethical and safety risks of such interventions.

WHAT HAPPENED: The
Federal Trade Commission (
FTC) and four
Republican-led states have filed a lawsuit against the
World Professional Association for Transgender Health (WPATH), alleging the organization misled parents and doctors about the safety and effectiveness of transgender “treatments” for
minors. The suit claims WPATH made deceptive assertions regarding puberty blockers, cross-sex hormones, and surgeries while
failing to adequately disclose risks.

DETAIL: The complaint alleges the group removed age-based recommendations from its standards of care and promoted treatments not adequately supported by evidence. FTC Chairman
Andrew Ferguson said parents have a right to make informed healthcare decisions for their children and accused
medical organizations of prioritizing profit over safety. The lawsuit is part of the
Trump administration’s broader effort to scrutinize medical interventions for
transgender minors. WPATH rejected the allegations, arguing the FTC’s actions are retaliatory and part of a broader campaign to undermine so-called gender-affirming care and the independence of the medical organizations that promote it.